Peptic ulcer in rheumatoid arthritis

Area of Science:

• Gastroenterology
• Rheumatology
• Internal Medicine

Background:

• Peptic ulcer disease is a common gastrointestinal complication.
• Rheumatoid arthritis (RA) patients often use non-steroidal anti-inflammatory drugs (NSAIDs), increasing ulcer risk.
• The prevalence and characteristics of peptic ulcers in RA patients require further investigation.

Purpose of the Study:

• To determine the prevalence of peptic ulcers in patients with rheumatoid arthritis (RA) and other rheumatic disorders.
• To identify risk factors associated with peptic ulceration in RA patients.
• To evaluate the efficacy of H2 receptor antagonists in healing peptic ulcers in this population.

Main Methods:

• Endoscopic examination of 230 patients (185 RA, 45 non-RA).
• Detailed gastrointestinal symptom history collection.
• Analysis of risk factors including smoking, NSAID use, and disease duration.

Main Results:

• Overall peptic ulcer prevalence was 36% (67/230 patients).
• Gastric ulceration was significantly more common in RA patients (17%) than non-RA patients (7%).
• 53% of RA patients with gastric ulcers were asymptomatic; smoking was a significant risk factor (63% vs 34%).
• No difference in NSAID duration or rheumatic disease duration between ulcer and non-ulcer groups.
• H2 receptor antagonist treatment achieved high healing rates for gastric (90%) and duodenal (85%) ulcers.

Conclusions:

• RA patients exhibit a higher prevalence of peptic ulcers, especially asymptomatic gastric ulcers.
• Smoking is a key risk factor for gastric ulcers in RA patients.
• H2 receptor antagonists are effective in healing peptic ulcers in rheumatic disease patients.